AMP Capital Investors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,522
| Closed | -$558K | – | 1329 |
|
|
2020
Q3 | $558K | Buy |
5,522
+597
| +12% | +$65.5K | ﹤0.01% | 910 |
|
|
2020
Q2 | $591K | Hold |
4,925
| – | – | ﹤0.01% | 884 |
|
|
2020
Q1 | $478K | Buy |
+4,925
| New | +$468K | ﹤0.01% | 890 |
|
|
2019
Q4 | – | Sell |
-4,908
| Closed | -$397K | – | 1251 |
|
|
2019
Q3 | $397K | Sell |
4,908
-7,353
| -60% | -$592K | ﹤0.01% | 1017 |
|
|
2019
Q2 | $945K | Sell |
12,261
-28,311
| -70% | -$2.65M | 0.01% | 897 |
|
|
2019
Q1 | $4.75M | Sell |
40,572
-25,918
| -39% | -$3.02M | 0.03% | 551 |
|
|
2018
Q4 | $6.98M | Buy |
66,490
+4,025
| +6% | +$467K | 0.04% | 414 |
|
|
2018
Q3 | $7.89M | Buy |
62,465
+4,931
| +9% | +$610K | 0.04% | 429 |
|
|
2018
Q2 | $6.51M | Buy |
57,534
+700
| +1% | +$76.9K | 0.04% | 482 |
|
|
2018
Q1 | $6.28M | Sell |
56,834
-13,003
| -19% | -$1.65M | 0.04% | 486 |
|
|
2017
Q4 | $10.3M | Buy |
69,837
+1,500
| +2% | +$191K | 0.06% | 368 |
|
|
2017
Q3 | $8.01M | Sell |
68,337
-9,977
| -13% | -$1.27M | 0.05% | 417 |
|
|
2017
Q2 | $10.3M | Buy |
78,314
+12,844
| +20% | +$1.6M | 0.06% | 338 |
|
|
2017
Q1 | $8.93M | Buy |
65,470
+12,581
| +24% | +$1.91M | 0.05% | 380 |
|
|
2016
Q4 | $7.61M | Sell |
52,889
-19,112
| -27% | -$2.44M | 0.05% | 418 |
|
|
2016
Q3 | $8.28M | Buy |
72,001
+3,776
| +6% | +$454K | 0.05% | 372 |
|
|
2016
Q2 | $7.07M | Buy |
68,225
+20,838
| +44% | +$2.32M | 0.05% | 389 |
|
|
2016
Q1 | $5.21M | Sell |
47,387
-26,051
| -35% | -$3.3M | 0.03% | 474 |
|
|
2015
Q4 | $11.6M | Buy |
73,438
+18,989
| +35% | +$2.76M | 0.08% | 276 |
|
|
2015
Q3 | $7.46M | Buy |
54,449
+35,060
| +181% | +$5.62M | 0.05% | 359 |
|
|
2015
Q2 | $3.31M | Buy |
19,389
+10,589
| +120% | +$1.9M | 0.02% | 572 |
|
|
2015
Q1 | $1.56M | Hold |
8,800
| – | – | 0.01% | 789 |
|
|
2014
Q4 | $1.15M | Sell |
8,800
-16,869
| -66% | -$2.17M | 0.01% | 864 |
|
|
2014
Q3 | $3.41M | Sell |
25,669
-900
| -3% | -$92.8K | 0.02% | 600 |
|
|
2014
Q2 | $2.38M | Sell |
26,569
-2,416
| -8% | -$232K | 0.01% | 708 |
|
|
2014
Q1 | $2.63M | Sell |
28,985
-38,534
| -57% | -$3.94M | 0.02% | 659 |
|
|
2013
Q4 | $7.58M | Sell |
67,519
-1,053
| -2% | -$95K | 0.05% | 409 |
|
|
2013
Q3 | $5.4M | Buy |
68,572
+1,300
| +2% | +$95K | 0.04% | 471 |
|
|
2013
Q2 | $4.33M | Buy |
+67,272
| New | +$4.33M | 0.03% | 525 |
|
Other funds holding UTHR
ACA
AMP Capital Investors's UTHR Position: Q4 2020 in Review
AMP Capital Investors sold out of United Therapeutics (UTHR) in Q4 2020, closing a stake of 5,522 shares — an estimated $558K sold.
AMP Capital Investors first reported a position in UTHR in Q2 2013 and held it in 29 quarters. The position peaked at $11.6M in Q4 2015. 356 funds tracked by Wall St. Rank hold UTHR as of Q4 2020.
- AMP Capital Investors reported no remaining United Therapeutics position as of Q4 2020 after selling out during the quarter.
- AMP Capital Investors sold 5,522 United Therapeutics shares in Q4 2020, an estimated $558K.
- AMP Capital Investors first reported a position in United Therapeutics in Q2 2013 and held it in 29 quarters.
- AMP Capital Investors's United Therapeutics position peaked at $11.6M in Q4 2015.
- 356 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2020.
Based on AMP Capital Investors's 13F filing for Q4 2020, filed 12 Feb 2021.